We only have this paper's title and publication details.
Read it at the sourceRetrospective data assess serum neurofilament light chain levels' effect on disease-modifying therapies in multiple sclerosis, suggesting potential clinical relevance.
To assess the utility of sNfL levels in a diverse MS population on variable efficacy DMTs.
No takes yet. Share an insight, caveat, or question.
Trivedi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: